Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER; ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. Saslow D, et al. Among authors: castle pe. CA Cancer J Clin. 2012 May-Jun;62(3):147-72. doi: 10.3322/caac.21139. Epub 2012 Mar 14. CA Cancer J Clin. 2012. PMID: 22422631 Free PMC article.
HPV genotype-specific prevalence and infection risks: A 10-year population-based study from the United States.
Wheeler CM, Adcock R, Hunt WC, Robertson M, Torrez-Martinez NE, McDonald R, Merchasin E, Jenison S, Saslow D, Joste NE, Castle PE, Kim JJ, Cuzick J; New Mexico HPV Pap Registry Steering Committee Members. Wheeler CM, et al. Among authors: castle pe. J Natl Cancer Inst. 2024 Dec 10:djae327. doi: 10.1093/jnci/djae327. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39658224
The Mulher Study: cervical cancer screening with primary HPV testing in Mozambique.
Salcedo MP, Lathrop E, Osman N, Neves A, Rangeiro R, Mariano AAN, Nkundabatware JC, Tivir G, Carrilho C, Monteiro ECS, Burny R, Thomas JP, Carns J, Andrade V, Mavume C, Paulo Mugolo R, Atif H, Hoover H, Chivambo E, Chissano M, Oliveira C, Milan J, Varon ML, Fellman BM, Baker E, Jeronimo J, Castle PE, Richards-Kortum R, Schmeler KM, Lorenzoni C. Salcedo MP, et al. Among authors: castle pe. Int J Gynecol Cancer. 2023 Dec 4;33(12):1869-1874. doi: 10.1136/ijgc-2023-004958. Int J Gynecol Cancer. 2023. PMID: 37907263
Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in Norway.
Hansen BT, Nygård M, Castle PE, Burger EA, Aasbø G. Hansen BT, et al. Among authors: castle pe. Int J Cancer. 2024 Sep 15;155(6):1053-1067. doi: 10.1002/ijc.34989. Epub 2024 May 15. Int J Cancer. 2024. PMID: 38751040 Clinical Trial.
506 results